abstract |
A method of treating Cardiovascular Diseases comprising administering of a compound of formula (I) (chemical names i.a. CS747 or Prasugrel; registry number 150322-43-3) or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, in conjunction with coronary and non-coronary intervention procedures is disclosed. |